logo

For the Inventor, By the Inventor

Carlsbad, CA, United States of America

Iwao Nozawa

This inventor holds 7 USPTO granted patents. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 1996-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Iwao Nozawa. Retrieved from https://idiyas.com/inventor/iwao-nozawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

% Patents Active = 85.7

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 195(Granted Patents)


Location History:

  • Tsukuba, JP (1996)
  • Tokyo, JP (1999 - 2002)
  • Carlsbad, CA (US) (2002 - 2005)

Company Filing History:

goldMedal7 out of 379 
 
Hisamitsu Pharmaceutical Company, Inc.
 patents

Years Active: 1996-2005

Loading Chart...
7 patents (USPTO):Explore Patents
1. 6978172 - Method for in vivo delivery of therapeutic agents (2005-12-20),
2. 6775569 - Electroporation device for in vivo delivery of therapeutic agents (2004-08-10),
3. 6490482 - Apparatus and method for in vivo delivery of therapeutic agents (2002-12-03),
4. 6444806 - Conjugates and methods of forming conjugates of oligonucleotides and carbohydrates (2002-09-03),
5. 6087172 - Ribozymes targeted to human IL-15 mRNA (2000-07-11),
6. 5874566 - Il-15 triplex oligonucleotides (1999-02-23),
7. 5573779 - Liposome composition (1996-11-12),

Title: Iwao Nozawa: Innovator in Electroporation Technology

Introduction

Iwao Nozawa is a prominent inventor based in Carlsbad, CA (US). He has made significant contributions to the field of therapeutic delivery systems, holding a total of 7 patents. His innovative work focuses on the development of devices that enhance the delivery of therapeutic agents through the skin and mucosal membranes.

Latest Patents

Iwao Nozawa's latest patents include a method for in vivo delivery of therapeutic agents using electroporation electrodes laminated to a permeable membrane. This electrode membrane is designed for continuous controlled delivery of therapeutic agents when placed in direct contact with the skin or mucosa, utilizing electric field pulses at specified intervals. Additionally, he has developed an electroporation device that incorporates an iontophoretic electrode within the same device, allowing for joint utilization in drug delivery through skin and mucosal membranes.

Career Highlights

Iwao Nozawa is currently associated with Hisamitsu Pharmaceutical Company, Inc., where he continues to innovate in the field of drug delivery systems. His work has been instrumental in advancing the technology that facilitates non-invasive therapeutic applications.

Collaborations

Throughout his career, Iwao Nozawa has collaborated with notable colleagues such as Shuji Sato and Kenji Mori. These partnerships have contributed to the development of cutting-edge technologies in the pharmaceutical industry.

Conclusion

Iwao Nozawa's contributions to electroporation technology and therapeutic delivery systems have positioned him as a key figure in the field. His innovative patents and collaborations continue to influence advancements in non-invasive medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…